AzTrials
AzTrials

Postoperative ComplicationsNCT00478348

Should Prosthetic Repair of Incisional Abdominal Hernias be Drain or Not?

A study testing Prosthetic repair of abdominal incisional hernia in people with Postoperative Complications and Hernia, run by University of Lausanne Hospitals at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether drainage after prosthetic repair of incisional abdominal hernias increases or decreases complications such as infection, seromas and hematomas. Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Postoperative Complications, Hernia
What is being tested?
Prosthetic repair of abdominal incisional hernia
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteSwitzerland
Study dates
May 2007to 10 Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Clinical diagnosis of midline abdominal wall incisional hernia
  • Adults of 20 to 80 years old
  • ASA I to III
  • Inform consent signed by the patient and investigators

Who cannot join

  • Incisional hernia less than 2 cm
  • Groin hernia
  • Antibiotic treatment before and during hospital admission
  • Emergency admission for strangulated incisional hernia
  • Immunosuppressing treatment

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Department of Visceral Surgery, University Hospital Center

    Lausanne, Canton of Vaud, 1011

Other trials in Switzerland

About this study

Official title: Adequacy of Drainage During Prosthetic Repair of Incisional Abdominal Hernias: a Randomized Controlled Trial.

The purpose of this study is to determine whether drainage after prosthetic repair of incisional abdominal hernias increases or decreases complications such as infection, seromas and hematomas.

Read the detailed description

Between 3 to 20% of patients who received a midline laparotomy will develop an incisional hernia.

Primary suture of the defect is associated with a recurrence rate between 25 and 50%.Mesh repair is superior with regard to the recurrence (12-20%), but early postoperative complications include infections, hematomas and seromas.

Some advocate the use of drains in order to diminish secretions and complications. Other claim that drains increase the complication's rate.

In the absence of a randomized controlled trial it's not clear whether drainage could influence positively or negatively the occurence of such complications when performing a prosthetic repair of abdominal incisional hernia.

The aim of this study is to answer this question, comparing prospectively two groups of operated patients: the former with drainage and the latter without.

Being tested
Prosthetic repair of abdominal incisional hernia
Keywords
Postoperative Complications, Drainage, Infection, Seroma, Hematoma, Recurrence, Abdominal Wall, Hernia, Surgical Mesh
Medical subject headings
Postoperative Complications, Hernia, Infections, Seroma, Hematoma, Recurrence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Prosthetic repair of abdominal incisional herniaProcedure or surgery

    Rives-Stoppa repair of incisional hernia

Study groups in NCT00478348
Study groupRoleWhat they receive
DrainOtherNot described
Receives: Procedure: Prosthetic repair of abdominal incisional hernia
No drainOtherNot described
Receives: Procedure: Prosthetic repair of abdominal incisional hernia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evidence of early clinical infection, hematoma, seroma or recurrence confirmed by ultrasonography or/and laboratory findings.

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 May 2007 (estimated)
  2. Study startMay 2007
  3. Primary completion1 Oct 2017
  4. Study completion10 Nov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00478348
Sponsor's protocol ID
DP-2007-CHV-UNIL
Status last verified
Nov 2017
First submitted
22 May 2007
Last updated
17 Nov 2017
Results posted
No
Data monitoring committee
Yes

Publications

  • Willemin M, Schaffer C, Kefleyesus A, Dayer A, Demartines N, Schafer M, Allemann P. Drain Versus No Drain in Open Mesh Repair for Incisional Hernia, Results of a Prospective Randomized Controlled Trial. World J Surg. 2023 Feb;47(2):461-468. doi: 10.1007/s00268-022-06725-4. Epub 2022 Dec 15.

    PubMed 36520177

Questions about this trial

What is this clinical trial studying?

A study testing Prosthetic repair of abdominal incisional hernia in people with Postoperative Complications and Hernia, run by University of Lausanne Hospitals at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evidence of early clinical infection, hematoma, seroma or recurrence confirmed by ultrasonography or/and laboratory findings. (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00478348, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in